Global HBV burden: guesstimates and facts

[1]  S. Alavian,et al.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. , 2018, The lancet. Gastroenterology & hepatology.

[2]  Organización Mundial de la Salud.  World health statistics 2017: monitoring health for the SDGs, Sustainable Development Goals , 2018 .

[3]  J. Kao,et al.  Prevention of mother-to-child transmission: the key of hepatitis B virus elimination , 2018, Hepatology International.

[4]  R. Tohme,et al.  Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015. , 2018, Vaccine.

[5]  C. Stasi.  GLOBAL BURDEN OF CHRONIC HEPATITIS B VIRUS INFECTION IN PRISON , 2017 .

[6]  A. Amato-Gauci,et al.  Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review , 2017, Epidemiology and Infection.

[7]  R. Tohme,et al.  The status of hepatitis B control in the African region , 2017, The Pan African medical journal.

[8]  J. Kao,et al.  Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. , 2017, Best practice & research. Clinical gastroenterology.

[9]  T. Tseng,et al.  Elimination of Hepatitis B: Is It a Mission Possible? , 2017, BMC Medicine.

[10]  D. Hedrich,et al.  Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  M. Thursz,et al.  Battlefield against hepatitis B infection and HCC in Africa. , 2017, Journal of hepatology.

[12]  R. Mikolajczyk,et al.  Time trends of chronic HBV infection over prior decades - A global analysis. , 2017, Journal of hepatology.

[13]  J. Kao,et al.  New perspectives of biomarkers for the management of chronic hepatitis B , 2016, Clinical and molecular hepatology.

[14]  T. Vos,et al.  Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[15]  A. Moorman,et al.  Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Noele P. Nelson,et al.  Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. , 2016, Clinics in liver disease.

[17]  S. Jiamsiri,et al.  Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[18]  Reza Assadi,et al.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.

[19]  J. Kao,et al.  Review article: novel therapies for hepatitis B virus cure – advances and perspectives , 2016, Alimentary pharmacology & therapeutics.

[20]  Shuqin Zhang,et al.  Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. , 2016, The New England journal of medicine.

[21]  S. Cowan,et al.  Undocumented migrant women in Denmark have inadequate access to pregnancy screening and have a higher prevalence Hepatitis B virus infection compared to documented migrants in Denmark: a prevalence study , 2016, BMC Public Health.

[22]  J. Alexander,et al.  Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization. , 2016, Vaccine.

[23]  B. McMahon,et al.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis , 2016, Hepatology.

[24]  B. McMahon,et al.  Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis , 2016, Hepatology.

[25]  Fares Alahdab,et al.  Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis , 2016, Hepatology.

[26]  N. Terrault,et al.  AASLD guidelines for treatment of chronic hepatitis B , 2016, Hepatology.

[27]  F. Souto.  Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21 st century. , 2016, Revista da Sociedade Brasileira de Medicina Tropical.

[28]  J. Zu,et al.  The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992-2006: A mathematical model analysis. , 2015, Journal of theoretical biology.

[29]  J. Kao.  Hepatitis B vaccination and prevention of hepatocellular carcinoma. , 2015, Best practice & research. Clinical gastroenterology.

[30]  E. Sagnelli,et al.  Hepatitis B virus burden in developing countries. , 2015, World journal of gastroenterology.

[31]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[32]  H. Whittle,et al.  Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia , 2015, Gut.

[33]  A. Lok,et al.  Hepatitis B virus infection , 2014, The Lancet.

[34]  S. Lo,et al.  Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus. , 2014, World journal of gastroenterology.

[35]  D. Corley,et al.  Prevention of vertical transmission of hepatitis B: an observational study. , 2014, Annals of internal medicine.

[36]  J. Sung,et al.  Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia. , 2013, Journal of hepatology.

[37]  J. Shim,et al.  Recent trends in hepatitis B virus infection in the general Korean population , 2013, The Korean journal of internal medicine.

[38]  A. Manirakiza,et al.  Cross-sectional study of hepatitis B virus infection in rural communities, Central African Republic , 2013, BMC Infectious Diseases.

[39]  J. Kao,et al.  Risk stratification for hepatitis B virus related hepatocellular carcinoma , 2013, Journal of gastroenterology and hepatology.

[40]  K. Kowdley,et al.  Prevalence of chronic hepatitis B among foreign‐born persons living in the United States by country of origin , 2012, Hepatology.

[41]  Gretchen A. Stevens,et al.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.

[42]  A. Wasley,et al.  The Increasing Burden of Imported Chronic Hepatitis B — United States, 1974–2008 , 2011, PloS one.

[43]  C. Auewarakul,et al.  High Incidence of Hepatitis B Infection-Associated Cirrhosis and Hepatocellular Carcinoma in the Southeast Asian Patients with Portal Vein Thrombosis , 2011, BMC gastroenterology.

[44]  Muhammad Idrees,et al.  Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes , 2011, Virology Journal.

[45]  G. Ioannou.  Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey , 2011, Annals of Internal Medicine.

[46]  H. El‐Serag,et al.  The changing pattern of epidemiology in hepatocellular carcinoma. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[47]  F. Mahoney,et al.  Case-control study to evaluate risk factors for acute hepatitis B virus infection in Egypt. , 2010, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[48]  M. Buendia,et al.  Statements from the Taormina expert meeting on occult hepatitis B virus infection. , 2008, Journal of hepatology.

[49]  A. Giannattasio,et al.  Long-term outcome in children with chronic hepatitis B: a 24-year observation period. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  F. Pujol,et al.  Hepatitis B virus genetic diversity in Latin America. , 2007, Virus research.

[51]  M. Kew,et al.  Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[52]  A. Prüss-Ustün,et al.  Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. , 2005, American journal of industrial medicine.

[53]  Mimi C. Yu,et al.  Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu‐speaking sub‐saharan Africans , 2005, Journal of medical virology.

[54]  J. Goedert,et al.  The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa , 2004, Hepatology.

[55]  Y. Hutin,et al.  The global burden of disease attributable to contaminated injections given in health care settings , 2004, International journal of STD & AIDS.

[56]  F. Mahoney,et al.  Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. , 2003, American journal of infection control.

[57]  P. León,et al.  Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. , 2003, Cadernos de saude publica.

[58]  S. Akhtar,et al.  Injections in health care settings: a risk factor for acute hepatitis B virus infection in Karachi, Pakistan , 2003, Epidemiology and Infection.

[59]  E. Christensen,et al.  Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B , 2000, Gut.

[60]  A. Al-Swailem,et al.  Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. , 1999, The Journal of infection.

[61]  W. Edmunds,et al.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr , 1996, Epidemiology and Infection.

[62]  T R Bender,et al.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.

[63]  R. Sampliner,et al.  Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. , 1982, American journal of epidemiology.